Preferred Name | Orlistat | |
Synonyms |
|
|
Definitions |
A reversible active-site inhibitor of gastrointestinal lipases. Orlistat forms a covalent bond with the active serine site in gastric and pancreatic lipases, thereby inhibiting their activity and preventing dietary fat from being hydrolyzed and absorbed. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C29303 |
|
CAS_Registry |
96829-58-2 |
|
Chemical_Formula |
C29H53NO5 |
|
code |
C29303 |
|
Contributing_Source |
FDA |
|
definition |
A reversible active-site inhibitor of gastrointestinal lipases. Orlistat forms a covalent bond with the active serine site in gastric and pancreatic lipases, thereby inhibiting their activity and preventing dietary fat from being hydrolyzed and absorbed. (NCI04) |
|
FDA_UNII_Code |
95M8R751W8 |
|
in_subset | ||
label |
Orlistat |
|
Legacy Concept Name |
Orlistat |
|
Preferred_Name |
Orlistat |
|
prefixIRI |
NCIT:C29303 |
|
prefLabel |
Orlistat |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0076275 |
|
subClassOf |
Create mapping